JPRN-UMIN000000723已完成未知
Feasibility study of weekly paclitaxel patients with pre-treatment (2 regimens) advanced/recurrent gastric cancer (OGSG 0602) - OGSG 0602
OGSG0 个研究点目标入组 22 人开始时间: 2007年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. cavity fluid which should be taken out 2. with double cancer and/or multiple cancer 3. patients with disorders on peripheral nerves 4. with active infectious disease which needs treatment 5. under the condition of diarrhea 6. with some mental and/or neural disorder which disturbs registration 7. under continuous steroids therapy 8. with other severe diseases(intestinal paralysis, intestinal obstruction, uncontrolled DM, pulmonary fibrosis, cardiac failure, or liver dysfunction) 9. pregnant and/or nursing women 10.with allergic history against medicines 11.with severe allergic response against medicine including cremoful 12.under Docetaxel or Paclitaxel therapy 13.doctors' stop not to register to the study
研究者
相似试验
已完成
2 期
Assessment of efficacy of weekly paclitaxel chemotherapy in ovarian cancersAdvanced Ovarian Cancer.Malignant neoplasm of ovaryIRCT2017050333789N1Taleghani Hospital- Shahid Beheshti University of Medical Sciences14
已完成
2 期
A phase II study of weekly paclitaxel in patients with advanced or recurrent esophageal cancer who had previously received docetaxel-containing chemotherapyAdvanced or recurrent esophageal cancerJPRN-UMIN000019230niversity of Miyazaki Hospital25
已完成
不适用
Feasibility study of weekly paclitaxel plus gemcitabine for metastatic and recurrent breast cancer with negative HER2Breast cancerJPRN-UMIN000007445Kyushu Breast Cancer Study Group40
招募中
2 期
Improving Performance status of Advanced lung cancer patients with ChemotherapyCTRI/2020/01/022617All India Institute of Medical Sciences
已完成
2 期
A phase II study of weekly paclitaxel for advanced or recurrent esophageal canceradvanced or reccurent esophageal cancerJPRN-UMIN000009807Medical Oncology, Hirosaki University Graduate School of Medicine30